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Graphical Abstract 
 
Highlights:  
 Seven GH29 α-L-fucosidases all possess transfucosylation activity 
 α-L-Fucosidase from F. graminearum catalyses formation of 2’FL from xyloglucan 
 α-L-Fucosidase CpAfc2 from C. perfringens efficiently catalyses formation of LNFP II 
 Systematic characterization of substrate specificity for seven GH29 α-L-fucosidases 
Abstract 
Human milk oligosaccharides (HMOs) constitute a unique family of bioactive lactose-based molecules 
present in human breast milk. HMOs are of major importance for infant health and development but also 
virtually absent from bovine milk used for infant formula. Among the HMOs, the fucosylated species are 
the most abundant. Transfucosylation catalysed by retaining α-L-fucosidases is a new route for 
manufacturing biomimetic HMOs. Seven α-L-fucosidases from glycosyl hydrolase family 29 were expressed, 
characterized in terms of substrate specificity and thermal stability, and shown to be able to catalyse 
transfucosylation. The α-L-1,3/4-fucosidase CpAfc2 from Clostridium perfringens efficiently catalysed the 
formation of the more complex human milk oligosaccharide structure lacto-N-fucopentaose II (LNFP II) 
using 3-fucosyllactose as fucosyl donor and lacto-N-tetraose as acceptor with a 39% yield. α-L-Fucosidases 
FgFCO1 from Fusarium graminearum and Mfuc5 from a soil metagenome were able to catalyse 
transfucosylation of lactose using citrus xyloglucan as fucosyl donor. FgFCO1 catalysed formation of 2’-
fucosyllactose, whereas Mfuc5 catalysis mainly produced an unidentified, non-HMO fucosyllactose, 
reaching molar yields based on the donor substrate of 14% and 18%, respectively.  
 
Abbreviations: 2’FL: 2’-fucosyllactose; 3FL: 3-fucosyllactose; A:D: acceptor-to-donor ratio; BbAfcB: α-1,3/4-
L-fucosidase from Bifidobacterium bifidum; CpAfc2: α-1,3/4-L-fucosidase from Clostridium perfringens; 
FgFCO1: α-L-fucosidase from Fusarium graminearum; FL: fucosyllactose; Fuc: fucose; GH: glycosyl 
hydrolase; GlcNAc: N-acetylglucosamine; HMO: human milk oligosaccharide; IMAC: immobilized metal 
affinity chromatography; LacNAc: N-acetyllactosamine; LNT: lacto-N-tetraose; LNnT: lacto-N-neotetraose; 
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LNFP: lacto-N-fucopentaose; Mfuc5: α-L-fucosidase from a soil metagenome; NixE: α-L-fucosidase from 
Xanthomonas campestris pv. campestris; pNP-α-L-Fuc: p-nitrophenyl α-L-fucopyranoside; TfFuc1: α-1,2-L-
fucosidase from Tannerella forsythia; TmαFuc: α-L-fucosidase from Thermotoga maritima; XXFG: defined 
nonasaccharide from xyloglucan; XXLG: defined octasaccharide from xyloglucan (defucosylated XXFG); XyG: 
xyloglucan.  
 
Keywords: α-L-Fucosidase; GH29; human milk oligosaccharides; substrate specificity; transfucosylation; 
xyloglucan Introduction  
Human milk oligosaccharides (HMOs) constitute a unique family of bioactive, heterogeneous carbohydrate 
oligomers present in human breast milk (5-15 g/L), which are known to be crucial for infant health and 
development through immunomodulatory effects as well as through selective stimulation of certain 
Bifidobacterium strains [1, 2, 3]. In brief, almost all HMO molecules have lactose (Gal-β1,4-Glc) at the 
reducing end and are biologically synthesized via sequential elongations of N-acetylglucosamine (GlcNAc) 
and galactose (Gal) moieties. The HMO backbone is then further modified with sialic acid (N-
acetylneuraminic acid) and/or fucose (Fuc) substitutions [1]. Over 180 different HMO species with different 
backbone lengths, types of substitutions, and bond configurations are known to exist – the vast majority 
being fucosylated species [4-6]. Only very few HMO species are present in bovine milk and only at 
infinitesimal concentrations [1], which is a challenge in production of valuable infant formula. Instead, 
prebiotic galactooligosaccharides (GOS) and fructooligosaccharides (FOS) are added to infant formula, but 
these are structurally different from the oligosaccharides occurring in milk and may therefore not elicit the 
same immune responses [2, 7]. Hence, a large incentive exists for biosynthetic production of authentic 
HMO structures for use in infant formula as well as in functional studies.  
 While metabolic engineering of Escherichia coli has recently been shown to allow direct microbial 
production of appreciable fucosyllactose (FL) yields [8-10], production of structurally more complex HMOs 
in engineered E. coli is still in its infancy [10, 11]. As a simpler alternative, direct enzymatic regiospecific 
synthesis of fucosylated HMOs in vitro employing α-L-fucosidases to catalyze transfucosylation is an option 
[12-15]. Retaining α-L-fucosidases are classified in glycosyl hydrolase (GH) family 29 (GH29), whereas 
inverting α-L-fucosidases are classified in GH95 (www.cazy.org [16]). For transglycosylation, only retaining 
glycosidases are relevant [17]. GH29 has been divided into two subfamilies – family GH29A and family 
GH29B – based on sequence homology which in turn designates substrate specificity. Family GH29A 
contains α-L-fucosidases with a relatively relaxed fucosyl substrate specificity, whereas the α-L-fucosidases 
in family GH29B are more regiospecific, targeting α-1,3- and α-1,4-linkages with a branched Gal only [18]. 
Several specific amino acids in the active site appear to be responsible for this difference in substrate 
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specificity [18, 19]. Consequently, regioselectivity in the transfucosylation reaction is more easily controlled 
with members of the GH29B subfamily [15, 19], but the strict regiospecificity also hinders the production of 
α-1,2-fucosylated glycans via transfucosylation catalysed by GH29B enzymes. 
So far, α-L-fucosidase-catalysed production of HMOs has been limited mainly by the lack of 
appropriate, fucosylated donor substrates [12, 14]. One natural suitable fucosyl donor substrate is plant cell 
wall derived xyloglucan (XyG), which features terminal α-1,2-fucosylation on certain side chains, the degree 
of fucosylation being dependent on the plant source [20, 21]. Only few α-L-fucosidases have been reported 
to release Fuc from XyG. Of these, most are inverting GH95 α-L-fucosidases from plants [22, 23], whereas 
reports on GH29 α-L-fucosidases include only the α-L-fucosidase FgFCO1 from Fusarium graminearum [24, 
25] and the α-L-fucosidase Mfuc5 from a soil metagenome [14]. The α-L-fucosidase TmαFuc from 
Thermotoga maritima has also been hypothesized to be able to release Fuc from XyG [26]; however, when 
tested alongside Mfuc5 the activity of TmαFuc on XyG was low [14]. The present work was undertaken to 
assess the option for employing microbial GH29 type A and B α-L-fucosidases for HMO production by 
transfucosylation using abundantly available industrial food-processing material as substrates, namely XyG 
extracted from citrus peel and lactose from milk whey. Finally, attempts to establish learning of α-L-
fucosidase specificity were made through studies of enzyme 3D structures and docking of an acceptor 
substrate. 
Materials & Methods 
Chemicals 
The synthetic substrate p-nitrophenyl α-L-fucopyranoside (pNP-α-L-Fuc) was purchased from Carbosynth 
Ltd. (Compton, UK). The fucosylated oligosaccharides 2’-fucosyllactose (2’FL), 3-fucosyllactose (3FL), lacto-
N-tetraose (LNT), lacto-N-neotetraose (LNnT), lacto-N-fucopentaose V (LNFP V), and the XyG 
nonasaccharide XXFG extracted from apple were purchased from Elicityl Oligotech (Crolles, France). L-
Fucose, β-lactose, and all other chemicals were purchased from Sigma-Aldrich (Steinheim, Germany). Dried 
citrus peel was supplied by Dupont Nutrition BioSciences ApS (Brabrand, Denmark) and stored at -20°C 
until use.  
Preparation of XyG from citrus peel  
20 g milled citrus peel was suspended in 1 L of 24% (w/v) KOH with 0.1 % (w/v) NaBH4 (the latter added to 
minimize backbone degradation by alkaline ‘peeling’) and stirred for 24 h [21, 27]. After centrifugation at 
5000 g for 30 min, the supernatant was neutralized with glacial acetic acid. The suspension was filtered on 
a 0.22 µm filter to remove large, suspended particles. Finally, the solution was diafiltered on a 5 kDa 
cellulose membrane (Vivaflow 200; Sartorius AG, Göttingen, Germany) against MilliQ water to remove 
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smaller molecules and salts. The retentate was freeze-dried and subjected to sulfuric acid hydrolysis as 
described previously [28] and monosaccharide composition was determined by HPAEC-PAD.  
Expression and purification of α-L-fucosidases 
Amino acid sequences for FgFCO1, TfFuc1, BbAfcB, CpAfc2, NixE, Mfuc5, and TmαFuc (Table 1) were 
retrieved from GenBank. Signal peptides and transmembrane regions were predicted using the online tools 
SignalP 4.1 [29] and TMHMM v. 2.0 [30]. Signal peptides were predicted for FgFCO1, TfFuc1, BbAfcB, 
CpAfc2, and NixE, and were removed from the sequence prior to insertion in the vector (Table 1). A 
transmembrane region at the C-terminus of BbAfcB was also removed (Table 1).  
The resulting genes encoding for FgFCO1, TfFuc1, BbAfcB, CpAfc2, and NixE were codon-optimized 
for expression in Escherichia coli (Table S1), synthesized and inserted into the vector pET22b(+) by 
GenScript (Piscataway, NJ) using the restriction sites given in Table 1. E. coli DH5α was used for plasmid 
propagation. E. coli BL21 (DE3) or E. coli BL21 (DE3) pLysS were transformed with the resulting plasmids and 
selected for ampicillin resistance (Table 1). For expression, transformants were grown in lysogenic broth 
(LB) supplemented with 100 µg/mL ampicillin at 37°C. When reaching an OD600 of 0.6-0.9, the temperature 
was reduced to 25°C (or 18°C for TfFuc1) and expression was induced with 1 mM IPTG. Cells were grown for 
20 h before being harvested.  Mfuc5 and TmαFuc were expressed from the pETM10 vector as described 
previously [14]. 
E. coli cells were harvested by centrifugation (5300 g, 15 min, 5°C) and the pellet was resuspended 
in binding buffer (20 mM sodium phosphate buffer, 20 mM imidazole, 500 mM NaCl, pH 7.4) and washed 
by centrifugation (5300 g, 15 min, 5°C). Again, the pellet was resuspended in binding buffer followed by 
sonication (10 rounds of 30 seconds at 100% amplitude and 60% cycle with 30-second breaks in between 
using a UP400S ultrasonicator (Hielscher Ultrasonics GmbH, Teltow, Germany)) to lyse the cells and 
centrifugation to remove cell debris (20000 g, 20 min, 5°C). The resulting supernatant was passed through a 
0.45 µm filter before being loaded onto a 4 mL Ni2+ Sepharose FF column (GE Healthcare, Uppsala, Sweden) 
for immobilized metal affinity chromatography (IMAC) purification. Unbound material was washed off with 
5-7 column volumes (CV) binding buffer. The α-L-fucosidases were eluted with 3 CV elution buffer (20 mM 
sodium phosphate buffer, 500 mM imidazole, 500 mM NaCl, pH 7.4) in 0.5 CV fractions. The IMAC-purified 
α-L-fucosidase preparations were desalted on PD-10 columns (GE Healthcare, Uppsala, Sweden) using a 
glycerol-free desalting buffer (20 mM sodium phosphate buffer, 100 mM NaCl, pH 7.4) to avoid 
interference of glycerol with HPAEC-PAD analysis. Protein purity was confirmed by SDS-PAGE and protein 
concentration was determined with Bradford reagent (Sigma-Aldrich, Steinheim, Germany) using bovine 
serum albumin (BSA) standards.  
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The gene encoding for FgFCO1 with a C-terminal His6-tag was codon-optimized for expression in 
Pichia pastoris (Table S1), synthesized and inserted into the vector pPICZα A by GenScript (Piscataway, NJ) 
using the restriction sites given in Table 1. After plasmid propagation in E. coli DH5α, the resulting 
linearized plasmid (prepared according to the EasySelectTM Pichia Expression Kit user manual, Invitrogen, 
2010) was transformed into P. pastoris X-33 by electroporation as described elsewhere [31]. Transformants 
were selected for Zeocin resistance and grown in buffered glycerol-complex medium (BMGY) for 24 h at 
30°C in shake flasks. After centrifugation (2000 g, 5 min), the pellet was resuspended in buffered methanol-
complex medium (BMMY) and grown for 72 h at 30°C with addition of new methanol (0.5% final 
concentration) every 24 h. The cultures were harvested by centrifugation (2000 g, 5 min), and the 
supernatant was ultrafiltered on a 10 kDa polyethersulfone membrane (Vivaspin 20; Sartorius AG, 
Göttingen, Germany). The resulting retentate was mixed 2:1 with concentrated binding buffer (60 mM 
sodium phosphate buffer, 60 mM imidazole, 1.5 M NaCl, pH 7.4), and the pH was adjusted to 7.4 before 
IMAC purification, which was carried out on a 5 mL HisTrap HP column (GE Healthcare, Uppsala, Sweden) 
using an ÄKTA purifier (GE Healthcare, Uppsala, Sweden) with the same binding and elution buffers as 
above, but using a linear gradient from 0 to 100% elution buffer over 5 CV for elution. The IMAC purified α-
L-fucosidase preparation was desalted and analysed as above. A sample of purified FgFCO1 was treated 
with Endo H (New England BioLabs Inc., Ipswich, MA) following the manufacturer’s instructions and 
analysed by SDS-PAGE.  
Hydrolytic activity 
Hydrolytic activity was determined for all α-L-fucosidases using a substrate concentration of 0.1 mM 
fucosylated substrate (pNP-α-L-Fuc, 2’FL, 3FL, XXFG, or XyG) in 50 mM buffer (acetate buffer for pH 5.0, 
phosphate buffer for pH 7.0, and glycine-NaOH buffer for pH 9.0) and enzyme concentrations of 0.05 µM or 
0.5 µM (for Mfuc5 also at 0.005 µM). For XyG extracted from citrus peel, the substrate concentration was 
0.1 mM bound Fuc as determined by acid hydrolysis (see 2.2). BbAfcB, NixE, FgFCO1, and TmαFuc were 
tested at pH 5.0, whereas CpAfc2, TfFuc1, and Mfuc5 were tested at pH 7.0. TfFuc1 was also tested at pH 
9.0 on pNP-α-L-Fuc. Negative controls without enzyme were included. All reactions took place at 40°C, 
were monitored for up to 20 min (180 min for XXFG and XyG), and stopped by mixing a sample 1:1 with 1 M 
Na2CO3 (resulting pH > 10). For pNP-α-L-Fuc, absorbance was measured at 405 nm and calibrated against a 
p-nitrophenol (pNP) standard curve. For all other substrates, the amounts of substrate and hydrolysis 
products were quantified by HPAEC-PAD analysis (see 2.7). Specific hydrolytic activity was defined as µmol 
product released per minute (U) per µmol of enzyme.  
Thermal stability 
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Purified α-L-fucosidases were incubated at temperatures from 40°C to 95°C for relevant time intervals up to 
1 h. Afterwards, the remaining hydrolytic activity was measured at standard conditions (40°C, pH 5.0 for 
NixE, FgFCO1, BbAfcB, and TmαFuc, pH 7.0 for Mfuc5, TfFuc1, and CpAfc2) on 0.1 mM substrate (pNP-α-L-
Fuc for Mfuc5, TmαFuc, NixE, and TfFuc1, 3FL for BbAfcB and CpAfc2, and 2’FL for FgFCO1) using enzyme 
concentrations of 0.05 µM (0.5 µM for FgFCO1). Reactions were performed as described in 2.4. To ensure 
linearity in the product release with time, reaction time was 5 min for pNP-α-L Fuc, 10 min for 3FL, and 15 
min for 2’FL. 
Transfucosylation activity 
For transfucosylation of LNT and LNnT, 3FL was used as donor substrate for reactions catalysed by BbAfcB 
and CpAfc2, whereas 2’FL was used as donor substrate with TmαFuc, FgFCO1, Mfuc5, TfFuc1, and NixE (LNT 
acceptor only). Enzyme concentration was 0.5 µM and reaction took place at 40°C for up to 60 min in 100 
mM buffer (acetate buffer pH 4.6 for FgFCO1 and TmαFuc, pH 5.0 for NixE, pH 5.5 for BbAfcB, phosphate 
buffer pH 7.0 for CpAfc2, Mfuc5, and TfFuc1). Reactions were terminated by heating at 99°C for 15 min. For 
reactions with an acceptor-to-donor ratio (A:D) of 10, donor substrate (2’FL or 3FL) concentration was 10 
mM and acceptor substrate (LNT or LNnT) concentration was 100 mM. For reactions with an A:D of 1, 
concentrations of donor and acceptor substrates were 20 mM. Transfucosylation products were identified 
and quantified by LC-ESI-MS using an external LNFP V standard (see 2.8). To aid the LNFP isomer 
identification, samples from the reactions were subjected to specific enzymatic hydrolysis as follows: A 
reaction sample was diluted 10 times in 100 mM acetate buffer (pH 5.0) and subjected to hydrolysis by 
either BbAfcB or TmαFuc at an enzyme concentration of 1 µM for 24 h at 40°C. The reaction was 
terminated by heating at 99°C for 15 min followed by LC-ESI-MS analysis.  
 For transfucosylation of lactose using the XyG-rich fraction from citrus peel, reactions took place at 
40°C for up to 24 h. The concentration of Fuc bound in XyG was 2 mM, the concentration of lactose was 
100 mM (A:D = 50), and the enzyme concentration was 2.5 µM. All reactions took place in 100 mM acetate 
buffer (pH 4.6 for FgFCO1 and TmαFuc, pH 5.0 for NixE) or 200 mM phosphate buffer (pH 7.0 for Mfuc5 and 
TfFuc1). Reactions were terminated by heating at 99°C for 15 min. Prior to analysis by HPAEC-PAD (see 2.7), 
the samples were filtered on a 5 kDa polyethersulfone membrane (Vivaspin 500, Sartorius AG, Göttingen, 
Germany) to remove large XyG molecules. 
HPAEC-PAD analysis 
High-performance anion exchange chromatography with pulsed amperometric detection (HPAEC-PAD) was 
carried out on a Dionex ICS3000 system (Dionex Corp., Sunnyvale, CA) using a CarboPacTM PA1 (4 mm x 250 
mm) analytical column equipped with a CarboPacTM PA1 (4 mm x 50 mm) guard column (Dionex Corp., 
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Sunnyvale, CA) and a flow rate of 1 mL/min at 25°C. The eluent system comprised MilliQ water (A), 500 mM 
NaOH (B), and 500 mM NaOAc with 0.02% (w/v) NaN3 (C).  
After enzymatic hydrolysis, 2’FL and 3FL were quantified by isocratic elution at 90:10:0 (% A:B:C) for 
30 min using external standards of L-fucose, lactose, 2’FL, and 3FL. Strongly retained anions were washed 
from the column by elution with 10:10:80 (% A:B:C) for 5 min followed by re-equilibration of the column at 
90:10:0 (% A:B:C) for 10 min. Similarly, enzymatic hydrolysis of XyG as well as enzymatic transfucosylation 
using XyG as donor and lactose as acceptor were quantified by isocratic elution at 95:5:0 (% A:B:C) for 30 
min (for XyG hydrolysis) or 45 min (for XyG transfucosylation) using external standards of L-fucose, lactose, 
2’FL, and 3FL (3FL was also used for quantification of the unidentified FL formed by Mfuc5). Strongly 
retained anions were washed from the column by elution with 15:5:80 (% A:B:C) for 5 min followed by re-
equilibration of the column at 95:5:0 (% A:B:C) for 10 min. For these analyses, the system was equipped 
with a post-column setup using 200 mM NaOH at a flow rate of 0.1 mL/min. The retention time of the self-
condensation product Fuc-Fuc-pNP was determined as outlined previously [14]. 
Enzymatic hydrolysis of XXFG was quantified by elution with a linear gradient from 80:20:0 (% 
A:B:C) to 60:20:20 (% A:B:C) from 0 to 30 min using external standards of XXFG and L-fucose. Furthermore, 
the identity of the resulting XXLG peak was confirmed by LC-MS (see 2.8). The XXLG peak was quantified as 
XXFG equivalents, and the results were validated against the L-fucose data. Strongly retained anions were 
removed by elution with 0:20:80 (% A:B:C) for 5 min followed by re-equilibration of the column at 80:20:0 
(% A:B:C) for 10 min.  
Monosaccharides were quantified using a Dionex ICS-5000 system (DionexCorp, Sunnyvale, CA, 
USA) equipped with a CarboPac PA1 analytical column (250 × 4 mm) and a CarboPac PA1 guard column 
(250 × 4 mm) operated at a flow rate of 1 mL/min at 25°C. The eluent system comprised MilliQ water (A) 
and 500 mM NaOH (B). The elution profile was as follows: isocratic elution 100:0 (% A:B) for 38 minutes, 
0:100 (%A:B) for 15 minutes, and re-equilibration 100:0 (% A:B) for 22 minutes. Detection was done by 
post-column addition of 500 mM NaOH at 0.2 mL/min. 
LC-ESI-MS analysis 
Identification and quantification of LNFP transfucosylation products were performed by liquid 
chromatography electrospray ionization mass spectrometry (LC-ESI-MS) on an Amazon SL iontrap (Bruker 
Daltonics, Bremen Germany) coupled to an UltiMate 3000 UHPLC from Dionex (Sunnyvale, CA USA). 5 µL 
sample was injected on a porous graphitized carbon column (Hypercarb PGC, 150 mm × 2.1 mm; 3 µm, 
Thermo Fisher Scientific. Waltham, MA, USA). The chromatography was performed at 0.4 mL/min at 70°C 
on a two-eluent system with eluent A (0.1% formic acid in water) and eluent B (acetonitrile). The elution 
profile was as follows: 0-1 min, 0% B; 1-28 min, linear gradient to 27.5% B; 28-31 min, linear gradient to 
AC
CE
PT
ED
 M
AN
US
CR
IPT
9 
 
60% B; 31-35 min, isocratic 60% B; 35-40 min, isocratic 0% B. The electrospray was operated in negative 
mode with UltraScan mode and a scan range from 100-1000 m/z, smart parameter setting of 850 m/z, 
capillary voltage at 4.5 kV, end plate off-set 0.5 kV, nebulizer pressure at 3.0 bar, dry gas flow at 12.0 L/min, 
and dry gas temperature at 280°C. CID fragmentation of deprotonated ions and formate adducts was 
performed by Multiple Reaction Monitoring using SmartFrag enhanced amplitude ramping from 80 to 
120%, fragmentation time 20 ms. Quantification was performed in Compass QuantAnalysis 2.2 (Bruker 
Daltonics, Bremen Germany) using LNFP V as external standard. Identification of FL transfucosylation 
products was carried out in the same manner using 2’FL and 3FL as external standards.  
Identification of XXFG-related compounds was performed on the same LC-ESI-MS, with the same 
eluents, but equipped with a TSK-GEL Amide-80 column (250 x 4.6 mm i.d., 5 μm, Tosoh Bioscience, Tokyo, 
Japan). The chromatography was performed at 1.0 mL/min at 55°C. The samples were diluted to a final 
concentration of 75% acetonitrile prior to injection. The elution profile was as follows: 0-5 min, 75% B; 5-65 
min, linear gradient to 25% B; 65-68 min, isocratic 10% B; 68-75 min, isocratic 75% B. The electrospray was 
operated in positive mode with a scan range from 100-2000 m/z, smart parameter setting of 1300 m/z, and 
nebulizer pressure at 5.0 bar. Sodium adducts were detected in auto MS2. All other settings as for LNFP 
compounds. 
Homology modelling and substrate docking 
The homology models for all enzymes (except for FgFCO1 and TmαFuc) were prepared using the built-in 
Homology Modeling function of YASARA Structure, version 16.9.23 (YASARA Biosciences GmbH, Vienna, 
Austria) [32]. In that process, the program automatically performs a sequence alignment with the available 
structure databases and picks the best templates. The covalent fucosyl-enzyme intermediates were 
prepared by docking α-L-Fuc into the homology models or available crystal structures respectively (for 
FgFCO1 (PDB 4NI3) and TmαFuc (PDB 2ZWY)). The YASARA dock_run macro was utilized without changes 
using a simulation cell of 125 Å3 around the active site Asp. The resulting docked models were compared to 
the TmFuc crystal structure in complex with an inhibitor (PDB 1HL9) to identify the most probable 
positioning of the ligand. Subsequently, a covalent bond was introduced between C1 of the α-L-Fuc and the 
sidechain oxygen of the active site Asp from the opposite side of the α-OH group using the Build function of 
the program. Afterwards, the α-OH group was replaced with a hydrogen atom. In this way, the retaining 
mechanism of GH29 fucosidases is simulated. Finally, the covalent intermediate models were refined using 
the md_refine macro of YASARA [33]. The structure with the lowest calculated energy was considered as 
the final covalent fucosyl-enzyme intermediate model. The resulting structures were analysed for tunnels 
using the CAVER 3.0 plugin for PyMOL [34]. Docking of acceptor molecules into the covalent intermediate 
models was carried out as described above except that the simulation cell was positioned around the 
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fucosyl residue. All figures showing 3D structures were prepared using PyMol (The PyMOL Molecular 
Graphics System, Version 1.1 Schrödinger, LLC). 
Statistics 
One-way ANOVA for determination of statistical significance was performed with JMP®, version 12.1.0 (SAS 
Institute Inc., Cary, NC). Statistical significance was established at p < 0.05.  
Results & Discussion 
Expression of α-L-fucosidases  
Seven α-L-fucosidases, which have all been characterized as retaining α-L-fucosidases in GH29, were 
selected, expressed, and studied in the current work in order to assess their ability to release Fuc from XyG 
as well as to investigate their transfucosylation potential (Table 1; Table 2). FgFCO1 and Mfuc5 were 
included based on their reported activity on XyG [14, 24]. In a phylogenetic tree, the α-L-fucosidase NixE 
from Xanthomonas campestris pv. campestris [35] was adjacent to FgFCO1 [14] and was therefore also 
included. Having shown activity towards terminal α-1,2-fucosyl moieties, the α-1,2-L-fucosidase TfFuc1 
from Tannerella forsythia [36] also appeared to be a good candidate for XyG utilization. Finally, TmαFuc 
which is probably the most studied α-L-fucosidase was included as a benchmark enzyme for these GH29A 
α-L-fucosidases [26, 37, 38]. In order to also study members of the GH29B subfamily and determine their 
potential for regioselective production of more complex HMO structures such as LNFP II and LNFP III, the α-
1,3/4-L-fucosidase BbAfcB from Bifidobacterium bifidum [39] and the recently characterized α-1,3/4-L-
fucosidase CpAfc2 from Clostridium perfringens [40] were included in the study. The former has previously 
been engineered into an α-1,3/4-L-fucosynthase [19] and its orthologue BiAfcB from Bifidobacterium 
longum subsp. infantis was recently studied and engineered to attain improved transfucosylation activity 
[15].   
Starting with the amino acid sequences listed in GenBank (Table 1), signal peptides were predicted 
by the SignalP 4.1 server [29] and subsequently removed from the sequences of FgFCO1, TfFuc1, BbAfcB, 
CpAfc2, and NixE prior to vector construction. No signal peptides were predicted in the deposited 
sequences of Mfuc5 or TmαFuc. In addition, presence of transmembrane regions was predicted by the 
TMHMM server v. 2.0 [30], and the predicted C-terminal region in BbAfcB was removed prior to vector 
construction (the resulting enzyme was truncated by another six amino acids compared to the truncated 
version expressed previously [39]). After inspection of homology models and previous expression reports 
[24, 35, 36, 39, 40], it was decided to place the desired His6-tag at the C-terminus of all α-L-fucosidase 
constructs made for the current work, i.e. FgFCO1, TfFuc1, BbAfcB, CpAfc2, and NixE. In Mfuc5 and 
TmαFuc, which were expressed previously [14], the His6-tag was N-terminal.  
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BbAfcB, CpAfc2, and NixE were successfully expressed in E. coli BL21 (DE3). Expression levels were 
38, 19, and 39 mg/L, respectively, when determined after IMAC purification and desalting by gel filtration. 
E. coli BL21 (DE3) did not grow in 400 mL-scale when transformed with vectors harbouring TfFuc1 and 
FgFCO1. Instead, TfFuc1 was expressed in E. coli BL21 (DE3) pLysS, but was only partially soluble (Figure 
S1b). Decreasing the temperature from 25°C to 18°C after IPTG induction increased the expression yield 
from 4.5 mg/L to 9 mg/L (determined after IMAC purification and desalting). The purity was assessed by 
SDS-PAGE, which also confirmed the expected molecular sizes (Figure S1; Table 2). 
FgFCO1 was only present in the insoluble fraction when expressed in E. coli BL21 (DE3) pLysS 
(Figure S1c). Instead, FgFCO1 – being of eukaryotic origin – was expressed in Pichia pastoris X-33 at 35 mg/L 
(determined after IMAC purification and desalting). The purity was assessed by SDS-PAGE, also confirming 
the expected molecular size of the glycosylated enzyme as well as of the EndoH treated protein (Figure S1d; 
Table 2 [25]).  
Hydrolytic activity  
The hydrolytic activity of the seven α-L-fucosidases was quantified on the synthetic substrate pNP-α-L-Fuc, 
on the HMO molecules 2’FL and 3FL, as well as on the XyG fragment XXFG – a defined nonasaccharide 
extracted from apple (see [20] or [27] for XyG unit nomenclature). In turn, the α-L-fucosidases active on 
XXFG were also tested on the XyG-rich fraction extracted from citrus peel (Table 3).  
 As expected, the GH29B α-L-fucosidases were only active on the α-1,3-fucosylated substrate 3FL 
(Table 3). Between them, BbAfcB (57 U/µmol) was significantly more active than CpAfc2 (17 U/µmol). This 
activity is in accordance with the linkage specificity previously reported [39, 40] and in agreement with 
their classification in subfamily GH29B, since these enzymes are generally only active on α-1,3- and α-1,4-
fucosylations and show no activity on pNP-α-L-Fuc [18]. Among the GH29A α-L-fucosidases, only Mfuc5 and 
TfFuc1 showed detectable activity on 3FL (3 U/µmol and 0.5 U/µmol, respectively).  
 GH29A α-L-fucosidases Mfuc5, TfFuc1, TmαFuc, and NixE were all active on pNP-α-L-Fuc, which was 
in accordance with literature data [14, 35-37] (Table 3). In contrast, FgFCO1 showed no detectable activity 
on pNP-α-L-Fuc; a very low activity of FgFCO1 on pNP-α-L-Fuc has indeed been described previously [24]. 
Mfuc5 had more than 5 times higher specific activity (582 U/µmol) on pNP-α-L-Fuc than TfFuc1 (106 
U/µmol), which in turn was twice as active as TmαFuc (47 U/µmol) and 5 times as active as NixE (21 
U/µmol). Indeed, Mfuc5 had a significantly higher specific activity than the other α-L-fucosidases on all the 
substrates (Table 3).    
 Focusing on the α-1,2-fucosylated substrates, Mfuc5 had similar specific activity on 2’FL (37 
U/µmol) and XXFG (34 U/µmol). For TfFuc1, NixE, FgFCO1 and especially for TmαFuc, the specific activity 
was lower on the XyG nonasaccharide XXFG as compared to the HMO 2’FL (Table 3). Among these four, 
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TfFuc1 was the more active on XXFG (1.7 U/µmol), whereas TmαFuc was the more active on 2’FL (7 
U/µmol). Apart from NixE, which has only been reported active on pNP-α-L-Fuc as well as on an α-1,3-
fucosylated N-glycan [35], all the GH29A have previously been reported active on 2’FL [14, 25, 36]. In 
contrast, only FgFCO1 has been reported active on XXFG [24] and Mfuc5 on citrus XyG [14]. The XXFG 
preparation contained an octasaccharide impurity (possibly XXF) which was hydrolysed at the same rate as 
the main XXFG component, indicating that such a small difference in substrate structure and size did not 
influence the catalytic efficiency (Figure S2).  
 Since all five GH29A α-L-fucosidases showed detectable activity on XXFG, their hydrolytic activity 
was also tested on XyG extracted from citrus peel. The XyG-rich substrate resulting from the alkaline 
extraction had a Fuc content of 14 mg per g dry matter corresponding to 2 mol% (Table S2). Again, Mfuc5 
was significantly more active than the other α-L-fucosidases with a specific activity of 8.4 U/µmol (Table 3), 
but the specific activity of Mfuc5 was 4 times lower on XyG than on XXFG. The activity decrease was even 
more severe for TfFuc1, NixE, and FgFCO1 – and for TmαFuc it was not possible to detect any activity on 
XyG at the tested enzyme concentration (0.5 µM; Table 3). A decrease in activity on XyG compared to XXFG 
may be expected since the small XXFG nonasaccharide is a much more accessible substrate than the large 
XyG polymer where the side chains wrap tightly around the backbone [21]. The same tendency, i.e. lower 
activity in higher molecular weight plant cell wall xyloglucan substrates, has also been observed for 
uncharacterized α-L-fucosidases present in plant extracts [41, 42]. Nevertheless, four of the tested GH29A 
α-L-fucosidases were in fact hydrolytically active on citrus XyG – and all five on the XXFG nonasaccharide – 
thus adding to the very few GH29 α-L-fucosidases known to be active on XyG.  
When studying the 3D structures of the active sites of the seven α-L-fucosidases, it was evident that 
the division into GH29 subfamilies A and B is indeed linked to the active site structure [18]: Among the α-L-
fucosidases studied in the current work, the two GH29B members CpAfc2 and BbAfcB showed an active site 
structure which was similar to each other, but markedly different from that of the GH29A α-L-fucosidases 
(Figure S3). Most of the GH29A α-L-fucosidases showed similar active site structures (Figure S3 c-f); 
however, the opening of the TmαFuc active site was partially shielded by a loop structure (Figure S3g). This 
may limit its access on a large substrate such as extracted XyG. 
Thermal stability  
The thermal stability of the seven α-L-fucosidases was tested by incubation at 40-95°C for up to 1 h 
followed by assessment of the remaining hydrolytic activity on the most preferred substrate, i.e. pNP-α-L-
Fuc for Mfuc5, TfFuc1, NixE, and TmαFuc, 2’FL for FgFCO1, and 3FL for BbAfcB and CpAfc2 (Table 3).  
All enzymes had half-lives above 9 h at 40°C (Table 4), justifying the use of this reaction 
temperature throughout the work. As expected, TmαFuc being of thermophilic origin was much more 
AC
CE
PT
ED
 M
AN
US
CR
IPT
13 
 
thermally stable than the other α-L-fucosidases. Among those, Mfuc5, TfFuc1, and NixE were the least 
thermostable with half-lives of 2-4 min at 55°C. Especially Mfuc5 appeared sensitive to temperature 
increases with a significantly lower half-life of just 48 min at 45°C (Table 4). FgFCO1, BbAfcB, and CpAfc2 
appeared more thermostable with half-lives of 2-8 h at 50°C and 28-42 min at 55°C (Table 4). CpAfc2 
appeared more stable than the others at 60°C with a half-life of 31 min, which was however still 3 times 
lower than that of TmαFuc (97 min) (Table 4; Figure S4).  
Transfucosylation activity 
Transfucosylation of LNT and LNnT with GH29B α-L-fucosidases 
HMO core structures LNT and LNnT were used as acceptors in transfucosylation catalysed by GH29B α-L-
fucosidases BbAfcB and CpAfc2 with 3FL as fucosyl donor in order to investigate the potential of these two 
enzymes in the production of more complex HMO molecules. Both enzymes could catalyse 
transfucosylation at an acceptor-to-donor ratio (A:D) of 10; however, CpAfc2 was much more efficient than 
BbAfcB (Figure 1a). For LNT, CpAfc2 reached a molar yield of LNFP II of 39% after 10 minutes of reaction, 
whereas the transient maximum yield for BbAfcB was only 13% after 5 minutes (Figure 1a). Considering the 
fact that BbAfcB was more than 3 times as hydrolytically active on 3FL than CpAfc2 (Table 3), the 
transfucosylation efficiency of BbAfcB is most likely hampered by its considerable hydrolytic activity as also 
evidenced by the rapid decline in LNFP II concentration from 5 to 30 minutes of reaction (Figure 1a). In fact, 
the hydrolytic activity of BbAfcB was reported to be even higher on LNFP II and LNFP III compared to 3FL 
[39]; thus, severe secondary hydrolysis was expected for BbAfcB. For CpAfc2, a transient maximum was also 
observed; however, the yield of LNFP II was still 30% after 30 minutes, confirming a lower rate of secondary 
hydrolysis in this enzyme (Figure 1a). Both enzymes exhibited much lower activity when using LNnT as 
acceptor, but CpAfc2 was still superior in transfucosylation compared to BbAfcB: with CpAfc2 a maximum 
LNFP III yield of 5% was reached after 10 min, whereas it was 1.4% for BbAfcB after 5 min, both being 
transient maxima (Figure 1a).  
For both enzymes, the expected strict α-1,3/4-regioselectivity of GH29B α-L-fucosidases was 
observed: with LNT an α1,4-linkage was formed to GlcNAc yielding LNFP II (Figure 2a) and with LNnT an α-
1,3-linkage was formed to GlcNAc yielding LNFP III (Figure 2b). Indeed, only α-1,3/4-fucosylation of the 
GlcNAc residues was detected by LC-ESI-MS (Figure S6; Figure S7), underlining the potential of these 
enzymes for highly specific HMO production (Figure 2). Interestingly, both enzymes clearly preferred the 
LNT acceptor, where the Gal moiety at the non-reducing end is β-1,3-linked to GlcNAc and the O-4 position 
is available for transfucosylation, over LNnT where the opposite is the case (Figure 1a; Figure 2).   
Since CpAfc2 was superior in transfucosylation, it was also tested at an A:D of 1. Previously, a yield 
of 6% LNFP II was reported when using the α-1,3/4-L-fucosidase BiAfcB from B. longum subsp. infantis and 
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20 mM 3FL as donor and 20 mM LNT as acceptor [15]. When tested at the same substrate concentrations, 
CpAfc2 showed a 35% yield of LNFP II after 35 min when using LNT and a 1.2% yield of LNFP III after 10 min 
when using LNnT (Figure 1b). Thus, for LNT the yield was not significantly lowered at an A:D of 1, although 
the transient maximum yield was reached 20 minutes later (Figure 1b). For LNnT where CpAfc2 had lower 
activity, the 10 times increase in A:D did however have a positive effect, i.e. the maximum yield of LNFP III 
was increased 4 times (Figure 1b). When studying the L321P/F34I mutant of BiAfbB engineered for 
improved transfucosylation activity at the same conditions, a 17% transfucosylation yield was obtained 
with LNT and 21% with LNnT [15]. Hence, the acceptor preference of mutated BiAfcB appears to be the 
opposite of BbAfcB and CpAfcB, which both had higher activity on LNT compared to LNnT (Figure 1a). 
The transfucosylation yield reported here for CpAfc2 is on the level of those reported for the best 
mutant of BiAfcB (L321P/F34I) at substrate concentrations of 200 mM [15]. Recently, yields as high as 60% 
were reached by introduction of a number of different amino acid substitutions in BiAfcB [43]. However, 
reaching a transfucosylation yield of 39% with WT CpAfc2 emphasizes its promising potential for future 
transfucosylation studies.  
Transfucosylation of LNT with GH29A α-L-fucosidases 
The α-L-fucosidases belonging to subfamily GH29A are known to be less regiospecific than those in GH29B 
[18]; thus, several reports on poor regioselectivity in transfucosylation catalysed by GH29A α-L-fucosidases 
exist [14, 38, 44]. Indeed, for the GH29A α-L-fucosidases two or three peaks corresponding to LNFP isomers 
were observed in the extracted ion chromatograms, indicating poor regioselectivity of these enzymes 
(Figure S8; Figure S9). In the current work, LNFP isomers were detected, identified, and quantified by LC-
ESI-MS aided by enzymatic hydrolysis of the obtained products by α-L-fucosidases TmαFuc and BbAfcB, 
which are specific towards α-1,2-fucosyl linkages and branched α-1,3/4-linkages, respectively (Table 3) [14, 
19, 39]. Known HMO LNFP isomers have characteristic fragment ions which can be used for identification 
by MS2 [45]. In the case of LNFP I which has an α-1,2-fucosylation on the non-reducing end Gal moiety, α-
1,3-, α-1,4-, or α-1,6-fucosylation on this moiety would give rise to the same m/z 325 fragment ion that is 
indicative of LNFP I. In contrast, the m/z 348 fragment ion indicative of LNFP II can only arise from LNFP II 
itself or from an isomer where Fuc is α-1,6-linked to GlcNAc. Such an isomer would not be hydrolysed by 
BbAfcB as LNFP II would [39], nor would it have a similar expected retention time on the PGC column since 
an α-1,6-linkage would result in a more planar structure than the α-1,4-linkage of LNFP II thus giving rise to 
a longer retention time of the isomer than of LNFP II [46]. 
The GH29A α-L-fucosidases Mfuc5, NixE, FgFCO1, TfFuc1, and TmαFuc, were used for 
transfucosylation of LNT with 2’FL as fucosyl donor. At an A:D of 10, all five enzymes catalysed formation of 
LNFP I isomers reaching total molar transfucosylation yields ranging from 10% to 35% within 60 minutes of 
AC
CE
PT
ED
 M
AN
US
CR
IPT
15 
 
reaction (Figure 3). In general, the specific hydrolytic activities of these enzymes towards FLs were lower 
than those of CpAfc2 and BbAfcB (Table 3), which may explain why no transient maximum was reached 
within the 60-minutes reaction time (Figure 3).  
 Of the five GH29A α-L-fucosidases, TfFuc1 exhibited superior transfucosylation activity reaching a 
total molar LNFP I isomer yield of 35% after 60 min of reaction. The total LNFP I isomer yields obtained with 
the other four enzymes were lower, but fairly similar: 18% with NixE, 15% with FgFCO1, 12% with Mfuc5, 
and 10% with TmαFuc (Figure 3). The low – but yet existent – transfucosylation activity of TmαFuc has 
previously been described, and has been dramatically improved by protein engineering [38]. The WT 
TmαFuc showed poor regioselectivity when transfucosylating pNP-β-Gal with pNP-α-L-Fuc as donor, 
whereas strict α-1,2-regioselectivity was observed in the best mutant (P25) [38]. However, when this 
mutant TmαFuc P25 was used for transfucosylation of LNT with 2’FL as donor, the main product was Fuc-
α1,3-LNT (13% yield) with a minor byproduct (1% yield) [15]. For all the GH29A α-L-fucosidases employed 
here, two or three LNFP I isomers were observed. However, the same isomer (herein called LNFP I isomer 
1) was dominant for all of them, and for FgFCO1, TmαFuc, and NixE the minor peaks never exceeded a 
transfucosylation yield of 0.2%, i.e. their transfucosylation activity on LNT was very regioselective towards 
formation of LNFP I isomer 1 (Figure 3a). Only this dominant peak was degraded in the TmαFuc-catalyzed 
hydrolysis, indicating that it has an α-1,2-linkage and is thus suggested to be LNFP I (Figure S10a-e). For 
TfFuc1, LNFP I isomer 1 corresponded to 93% of the total LNFP produced, but for Mfuc5 the regioselectivity 
was poorer: the yield of LNFP I isomer 1 was 7.3% while that of LNFP I isomer 2 was 4.2%, corresponding to 
53% and 31% of the total LNFP, respectively (Figure 3b). LNFP I isomer 2 and LNFP I isomer 3 (observed only 
for FgFCO1 and only in trace amounts) were only partially degraded by TmαFuc after 24 h, indicating that 
the terminal Fuc is attached by an α-1,3-, α-1,4-, or α-1,6-linkage (Figure S10a-e). Neither of the LNFP I 
isomers were degraded by BbAfcB, which is active on α-1,3/4-fucosylations with a branched Gal residue 
and thus not expected to be active on the linear LNFP I isomers [19, 39] (Figure S10a-e).  
 The poor regioselectivity of the GH29A α-L-fucosidases TfFuc1 and Mfuc5 was not confined to 
mixed linkage formation on the non-reducing Gal moiety. Indeed, an LNFP II isomer was also detected in 
the transfucosylation catalysed by Mfuc5 and TfFuc1 (Figure 3b). Given its long retention time on the PGC 
column, the fact that it was not hydrolysed by BbAfcB (Figure S10d-e), and the reported hydrolytic activity 
of TfFuc1 on α-1,6-fucosyl linkages [36], this is likely to be an LNFP II isomer where Fuc is α-1,6-linked to 
GlcNAc. In comparison, LNFP II produced by BbAfcB and CpAfc2 (Figure 1; Figure 2) was completely 
hydrolysed by BbAfcB and had a shorter retention time on the PGC column (Figure S10f-g). For Mfuc5 – the 
least regiospecific of the two – a 2.2% yield of this LNFP II isomer was detected, corresponding to 16% of 
the total LNFP produced. For TfFuc1, the yield of the LNFP II isomer obtained within 60 min was only 0.6%, 
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corresponding to less than 2% of the total LNFP (Figure 3b). The low regioselectivity of Mfuc5 was also 
observed previously [14].  
Transfucosylation of lactose using XyG as donor substrate 
Searching for a natural and abundant fucosyl donor, the main aim of the current work was to assess the 
activity of the α-L-fucosidases on XyG – and not least to determine their ability to use XyG as fucosyl donor 
in transfucosylation. Aiming at industrial application, lactose was used as acceptor substrate since it is 
abundant in dairy products and side streams. The four GH29A α-L-fucosidases which had exhibited 
hydrolytic activity on XyG, i.e. FgFCO1, NixE, TfFuc1, and Mfuc5 were tested in transfucosylation of 100 mM 
lactose using the XyG-rich fraction extracted from citrus peel as donor at a concentration corresponding to 
2 mM bound Fuc. The reaction was monitored for up to 24 h (Figure 4).  
 FgFCO1 catalysed formation of 2’FL reaching a molar yield based on the donor of 8% after 4 h and 
14% after 24 h (Figure 4a). Interestingly, the rate of formation of 2’FL initially exceeded that of Fuc; 
however, after 24 h the concentration of released Fuc was twice as high as the 2’FL concentration (Figure 
4a). No other FL isomers were detected (Figure S11). The specific hydrolytic activity of FgFCO1 on 2’FL is 
low (Table 3), and this appears to be reflected in the transfucosylation of lactose with XyG, where no 
transient maximum was observed within the 24 h of reaction (Figure 4).  
 As previously reported [14], the main transfucosylation product of Mfuc5 was an unidentified FL, 
which was neither 2’FL nor 3FL (Figure S11). The formation of the unidentified FL reached a transient 
maximum yield of 18% after 2 h (Figure 4d). Small amounts of 2’FL were also formed, the maximum yield 
being 0.6% after 3h. Compared to FgFCO1, the formation of free Fuc was much higher for Mfuc5, 
confirming the markedly higher hydrolytic activity of this enzyme (Table 3; Figure 4d).  
For FgFCO1 and Mfuc5, the transfucosylation yields obtained with XyG and lactose (14% and 18%, 
respectively) were comparable to those obtained with 2’FL and LNT (15% and 14%, respectively; Figure 3). 
For NixE and TfFuc1, which had specific hydrolytic activities on XyG compared to that of FgFCO1 (Table 3), 
this was not the case. Indeed, NixE showed only hydrolytic activity on XyG (Figure 4b). Similarly, TfFuc1 
showed mainly hydrolytic activity on XyG with only negligible amounts of 2’FL formed, i.e. the maximum 
level of 2’FL detected by HPAEC-PAD after 4 h corresponded to a molar yield on the fucosyl donor of 0.7% 
(Figure 4c). The product could not be detected by LC-MS (Figure S11). This result is especially striking for 
TfFuc1, which was superior in terms of yields in the LNT transfucosylation (Figure 3). Possibly, lactose is a 
poor acceptor substrate for TfFuc1. Indeed, in a preliminary transfucosylation study using 10 mM pNP-α-L-
Fuc as donor and 100 mM lactose as acceptor at pH 7.0 and 45°C, TfFuc1 mainly catalysed the formation of 
the self-condensation product Fuc-Fuc-pNP (linkage unknown) and only trace amounts of 2’FL, whereas the 
main product of Mfuc5 was the unidentified FL with Fuc-Fuc-pNP as a side product. Similarly, an α-L-
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fucosidase from Alcaligenes sp. had higher transfucosylation activity with N-acetyllactosamine (LacNAc) as 
acceptor than with lactose and the same was the case for their β-O-methylated derivatives; although the 
fact that A:D was 25 for LacNAc and 19 for lactose may have influenced the result, the presence of the N-
acetyl group on the reducing end GlcNAc residue still significantly improved the transfucosylation on the 
non-reducing end Gal residue [47]. Thus, the acceptor specificity of TfFuc1 may be more limited than 
usually seen for other retaining glycosidases [12]. In the homology modelled 3D structure of TfFuc1, a 
tunnel is observed at the acceptor binding site (Figure 5a-b); this was not observed for the other α-L-
fucosidases investigated here (Figure S3). When docking the lactose acceptor into the TfFuc1 3D structure, 
it is situated too deep inside the tunnel to function as acceptor substrate (Figure 5c). This may explain why 
LNT (which has lactose at the reducing end of the tetraose structure) was observed to be a markedly better 
acceptor for TfFuc1-catalysed transfucosylation than lactose. In contrast, docking lactose into the covalent 
intermediate model of FgFCO1 lead to a positioning of the 2’-OH group between the covalently bound C1 of 
Fuc and the general base E288 (Figure 5d). 
TmαFuc was also tested for XyG transfucosylation since it had shown detectable hydrolytic activity 
on the XXFG nonasaccharide, but as expected from its hydrolytic activity on XyG (Table 3) and from 
previous results [14], neither hydrolytic nor transfucosylation activity was observed on citrus peel XyG. 
Using immune-glycan microarrays, some hydrolytic activity of TmαFuc was previously detected on XyG 
from Arabidopsis thaliana and Sambucus nigra; however, this activity was very low compared to that of 
Mfuc5 [14]. As hypothesized above, XyG accessibility may be limited for TmαFuc by the loop structure at 
the entrance to its active site (Figure S3g). As previously shown for sialidases, transglycosylation activity is 
not only linked to how open the active site binding pocket is, but also to specific interactions inside or near 
the active site [48]. Indeed, in the current work both donor and acceptor specificities of each α-L-fucosidase 
seem to influence their transfucosylation potential significantly.    
Conclusions 
In conclusion, FgFCO1 was the most promising α-L-fucosidase for transfucosylation from citrus peel XyG, 
showing better regioselectivity leading to the formation of a true HMO structure and lower hydrolytic 
activity than Mfuc5. The GH29B type α-L-fucosidase CpAfc2 showed promising potential in the 
transfucosylation of LNT using 3FL as donor substrate reaching a 39% yield of LNFP II. Using 3FL or 2’FL as 
donor substrates, all seven α-L-fucosidases were able to catalyse transfucosylation of LNT at an A:D of 10 
with varying regioselectivity. For CpAfc2, decreasing A:D to 1 did not decrease the yield significantly.  
Recently, α-L-fucosidase activity was discovered in a strain of Fusarium proliferatum able to grow 
on pure fucoidan. While no fucoidanase activity could be detected, significant α-L-fucosidase and 
arylsulfatase activites were observed [49]. A GH29 α-L-fucosidase, which has only 25% amino acid sequence 
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identity to FgFCO1, was purified from this strain and was shown to catalyse transfucosylation of various 
pNP-glycosides and aliphatic alcohols using pNP-α-L-Fuc as donor substrate [50]. Being plant pathogens, the 
Fusarium sp. may prove to be a good source for discovery of α-L-fucosidases active on biomass substrates, 
which can be used for enzymatic transfucosylation.  
The perspective of the findings relates to the abundance of the produced fucosylated compounds. 
Depending on the blood group of the mother, 30-65% of the HMOs are fucosylated [6]. Of these, HMOs 
with α-1,2-fucosylation are the most prevalent ones with 2’FL being the most abundant HMO [5, 6]. 
However, α-1,2-fucosylated HMOs are absent from the milk of so-called non-secretors, i.e. mothers who 
lack the SE gene encoding the human α-1,2-fucosyltransferase FUT2, although some exceptions have been 
encountered [51]. It is commonly accepted that 20% of women are non-secretors, even though this 
percentage varies slightly depending on ethnic group [5, 52, 53]. For non-secretors, the most prevalent 
fucosylated HMO appears to be LNFP II [6], but 3FL has also been reported as being abundant in the milk of 
non-secretors [5]. Thus, except for the mix of LNFP isomers produced with the GH29A α-L-fucosidases and 
the unidentified non-HMO FL produced by Mfuc5, all the structures reported in the current 
transfucosylation studies on GH29A and GH29B α-L-fucosidases are of interest for regioselective production 
as well as for functional studies.  
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Figure legends 
Figure 1. a) Transfucosylation of LNT and LNnT with GH29B α-L-fucosidases CpAfc2 (black) and BbAfcB 
(grey) using 3FL as fucosyl donor. Transfucosylation yields are given as % molar yields on donor substrate. 
Reactions took place at 40°C using 10 mM 3FL, 100 mM LNT or LNnT (A:D = 10), and an enzyme 
concentration of 0.5 µM; pH was 5.5 for BbAfcB and 7.0 for CpAfc2. b) Giving highest transfucosylation 
yields as A:D = 10 (shown in a) and with filled symbols), CpAfc2 was also tested at A:D = 1 using 20 mM 3FL 
and 20 mM LNT or LNnT (open symbols). The transfucosylation products were identified and quantified by 
LC-ESI-MS using an external LNFP V standard. By MS2 fragmentation, the single reaction product was 
identified as LNFP II when using LNT acceptor and as LNFP III when using LNnT acceptor (Figure S6; Figure 
S7; Figure 2). Standard deviations of duplicate reactions are indicated.  
Figure 2. Transfucosylation of LNT (a) and LNnT (b) using 3FL as donor and GH29B α-L-fucosidases BbAfcB 
and CpAfc2. Since the main activity of the α-L-fucosidases is hydrolytic, free Fuc and lactose is also formed.   
Figure 3. Transfucosylation of LNT with GH29A α-L-fucosidases FgFCO1, TmαFuc (pH 4.6), NixE (pH 5.0), 
Mfuc5, and TfFuc1 (pH 7.0) using 2’FL as fucosyl donor. Transfucosylation yields are given as molar yields 
on donor substrate. Reactions took place at 40°C using 10 mM 2’FL, 100 mM LNT (A:D = 10), and an enzyme 
concentration of 0.5 µM. The transfucosylation products were identified and quantified by LC-ESI-MS using 
an external LNFP V standard (Figure S5; Figure S8; Figure S9). For all, LNFP I isomer 1, which is suggested to 
be LNFP I based on enzymatic product hydrolysis data (Figure S10), was the main transfucosylation product 
(a-b, filled black symbols). For Mfuc5 and TfFuc1 an LNFP II isomer believed to have an α-1,6-fucosylation 
on GlcNAc was also detected (b, filled grey symbols), but in negligible amounts. Standard deviations of 
duplicate reactions are indicated.  
Figure 4. Transfucosylation from XyG to lactose. Release of Fuc and formation of FLs tested at 40°C using 
2.5 µM enzyme, 2 mM Fuc bound in XyG from citrus peel, 100 mM lactose, and a) FgFCO1 at pH 4.6, b) NixE 
at pH 5.0, c) TfFuc1 at pH 7.0, and d) Mfuc5 at pH 7.0 (100 mM acetate buffer for pH 4.6-5.0 and 200 mM 
phosphate buffer for pH 7.0). Fuc (black circles), 2’FL (grey triangles), and unidentified FL (open squares) 
were quantified by HPAEC-PAD. Standard deviations of duplicate samples are indicated. The unidentified FL 
eluted around the same time as 3FL on HPAEC-PAD, but LC-MS analysis confirmed that it was not 3FL 
(Figure S11) as has also been observed previously [14]. The identity of 2’FL was confirmed by LC-MS 
analysis (Figure S11).  
Figure 5. The TfFuc1 tunnel (a-b) and lactose docking into TfFuc1 (c) and FgFCO1 (d). A tunnel (green 
spheres) going deep into the structure of TfFuc1 was observed after homology modelling for the enzyme 
without substrate (a). For the covalent intermediate model this tunnel (green spheres) was found to be 
elongated and even reaching the enzyme surface (b). The lactose molecule docked into the covalent 
intermediate model was bound inside the tunnel of TfFuc1 (c), whereas it was positioned with the 2’-OH 
group between the C1 of covalently bound Fuc and the general acid/base residue E288 in FgFCO1 (d). 
Colour coding: active site nucleophile D214 (TfFuc1) or D226 (FgFCO1; green), covalently bound L-Fuc which 
adopts β-conformation at this step in the double displacement mechanism (cyan), Lac (purple), 
general/acid base residue E288 (FgFCO1; yellow). 
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Tables 
Table 1. Microbial origin, GenBank accession numbers, vectors, and expression strains used for production 
of α-L-fucosidases in the current work.  
Enzyme 
name 
Organism GenBank no. Vector Features1 AAs 
inserted2 
Expression 
strain  
FgFCO1 Fusarium graminearum 
PH-1 
AFR68935.1 pPICZα A  
(EcoRI, 
XbaI) 
His6 (C), Myc 
(C), α-factor, 
ZeoR 
26-609 (end) P. pastoris X-33 
FgFCO1 Fusarium graminearum 
PH-1 
AFR68935.1 pET22b(+) 
(NcoI, XhoI)3 
His6 (C), pelB, 
AmpR 
26-609 (end) E. coli BL21 
(DE3) pLysS 
TfFuc1 Tannerella forsythia ATCC 
43037 
AEW21393.1 pET22b(+) 
(NcoI, XhoI)3 
His6 (C), pelB, 
AmpR 
21-446 (end) E. coli BL21 
(DE3) pLysS4 
BbAfcB Bifidobacterium bifidum 
JCM 1254 
BAH80310.1 pET22b(+) 
(NdeI, XhoI) 
His6 (C), AmpR 38-1462 E. coli BL21 
(DE3)  
CpAfc2 Clostridium perfringens 
ATCC 13124 
ABG83106.1 pET22b(+) 
(NcoI, XhoI)3 
His6 (C), pelB, 
AmpR 
26-932 (end) E. coli BL21 
(DE3)  
NixE Xanthomonas campestris 
pv. campestris ATCC 
33913 
AAM42160.1 pET22b(+) 
(NdeI, XhoI) 
His6 (C), AmpR 40-561 (end) E. coli BL21 
(DE3)  
Mfuc55 - AIC77302.1 pETM-10 
(NcoI, KpnI) 
His6 (N), KanR 1-419 (end) E. coli C41 
(DE3) 
TmαFuc
5 
Thermotoga maritima 
MSB8  
AAD35394.1 pETM-10 
(NcoI, KpnI) 
His6 (N), KanR 1-449 (end) E. coli BL21 
(DE3) pLysS4 
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1Disulfide bridges were predicted via the DiANNA 1.1 software tool [54] and inspection of 3D structures (from PBD or homology 
models made with HHPred and MODELLER [55]). In case of clear evidence of disulfide bridges, a pelB leader sequence was included 
(using NcoI), except for BbAfcB, which was previously successfully expressed without [39]. N or C designates the placement of the 
His6-tag.2Signal peptides and transmembrane regions were predicted using the SignalP 4.1 server [29] and the TMHMM server v. 
2.0 [30]. All predicted signal peptides were removed from the sequence prior to insertion into the vector. 3An extra Gly at the N-
terminal resulted from adding additional nucleotides to keep the reading frame. 4Expression was first tested in E. coli BL21 (DE3), 
but turned out to be significantly improved in E. coli BL21(DE3) pLysS. 5Expression done and described previously [14].  
 
 
 
 
Table 2. GH29 subfamily and properties (optimal conditions, size, and quaternary structure) reported in the 
literature for the α-L-fucosidases [14, 24, 25, 35-37, 39, 40], along with the apparent size of the expressed 
α-L-fucosidases as determined by SDS-PAGE (Figure S1) and their expression yields. 
 
 Subfamily
1 
pHopt Topt Size Apparent size Expression yield2 
FgFCO1  A 4.6 - 66 kDa3 70 kDa (75 kDa glycosylated) 35 mg/L 
TfFuc1 A 94 - 51 kDa  48 kDa 9 mg/L 
BbAfcB B 5.5-6 45°C 160 kDa 150 kDa 38 mg/L 
CpAfc2 B 7 40°C 101 kDa  100 kDa 19 mg/L 
NixE A 5 37°C 58 kDa 55 kDa 39 mg/L 
Mfuc5 A 7 40°C 48 kDa 50 kDa5 - 
TmαFuc A 4.5 ≥60°C 52 kDa 50 kDa5 - 
1The subfamily division was first proposed by Sakurama and co-workers [18]; the designation here is derived from the phylogenetic 
tree presented in [14] and the multiple sequence alignment in [40]. 2Determined after IMAC purification and desalting. 3Apparent 
size of deglycosylated enzyme; based on SDS-PAGE the size was approx. 70 kDa with glycosylation (produced in P. pastoris) [25]. 
4Optimal pH reported to be 9.0 [36], but in the current work TfFuc1 had similar hydrolytic activities on pNP-α-L-Fuc at pH 7.0 and 
pH 9.0, with indications of inactivation over time at pH 9.0 (data not shown). 5Data from [14].  
 
 
Table 3. Hydrolytic activity of the expressed α-L-fucosidases. Activity given as µmol product released per 
minute (U) per µmol of enzyme for all substrates. The reaction temperature was 40°C and pH was 5.0 for 
NixE, FgFCO1, TmαFuc, and BbAfcB, and 7.0 for Mfuc5, TfFuc1, and CpAfc2. Only enzymes active on XXFG 
were tested on the XyG-rich fraction from citrus peel. Standard deviations of duplicate reactions are 
indicated. The GH29 subfamily is indicated since it relates to substrate specificity. Superscript letters 
indicate significant difference between enzymes for each substrate.  
 
 Subfamily pNP-α-L-Fuc XXFG XyG 2'FL 3FL 
Mfuc5 A 582 ± 51a 34.1 ± 4.5a 8.4 ± 0.02a 37.0 ± 2.8a 2.8 ± 0.5c 
TfFuc1 A 106 ± 1.3b  1.7 ± 0.1b 0.03 ± 0b 3.0 ± 0.5c 0.5 ± 0.1d 
NixE A 21.2 ± 0.5c 0.5 ± 0.03b 0.01 ± 0.002b 3.7 ± 0bc 0 
FgFCO1 A 0 0.3 ± 0.02b 0.03 ± 0.002b 1.1 ± 0.3c 0 
TmαFuc A 47.3 ± 5.1bc 0.1 ± 0.01b 0 7.0 ± 0.5b 0 
BbAfcB B 0 0 - 0 57.0 ± 1.4a 
CpAfc2 B 0 0 - 0 17.2 ± 0.2b 
 
 
 
Table 4. Thermal stability of the expressed α-L-fucosidases. Enzyme samples were incubated at 40-95°C for 
up to 1 h and the residual activity was measured at standard conditions (Figure S4). Half-lives (t½) are given 
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in min ± standard deviations of duplicate reactions. Empty fields indicate that the enzymes were not tested 
at the given temperature, whereas the hyphen indicates that the first-order thermal inactivation constant 
kD = 0 (Figure S4). Superscript letters indicate significant difference between half-lives of the enzymes at 
each temperature (p < 0.05).  
 
Incubation 
temperature Mfuc5 TfFuc1 NixE FgFCO1 BbAfcB CpAfc2 TmαFuc 
40°C 790 ± 
257b -  573 ± 86b 
621 ± 
174b >1740a 780 ± 17b - 
45°C 
48 ± 1.1c 355 ± 84ab 419 ± 67ab 
455 ± 
238a 556 ± 259a 171 ± 14bc  
50°C 6.2 ± 
0.02e 14 ± 0.9e 24 ± 2.3de 244 ± 15b 493 ± 162a 113 ± 14cd 134 ± 27c 
55°C 1.7 ± 
0.02c 3 ± 0.05c 4.3 ± 0.05c 39 ± 2.5a 28 ± 1.6b 42 ± 6.3a  
60°C 0.7 ± 
0.01c 1.6 ± 0.01c 2.2 ± 0.02c 6.0 ± 0.4c 4.7 ± 0.08c 30.6 ± 3.4b 97 ± 28a 
70°C       28 ± 3.4 
80°C       19 ± 2.9 
90°C       15 ± 0.7 
95°C       4.4 ± 0.03 
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Figr-3
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Figr-4
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Figr-5
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